Forget the Retail Tech Glitz: I Am Loading Up on This Unassailable Enterprise Cash Cow

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • MSFT's Azure grew 40% and AI revenue hit a $37 billion annualized run rate while the stock trades at just 19 times forward earnings.

  • Capex nearly doubled to $31 billion, but operating cash flow grew 26% as Microsoft's customers fund the AI buildout in real time.

  • Thirteen board members bought shares during the June dip, and commercial backlog surged 99% to $627 billion, locking in years of contracted revenue.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Microsoft didn't make the cut. Grab the names FREE today.

Forget the Retail Tech Glitz: I Am Loading Up on This Unassailable Enterprise Cash Cow

© Mariakray / iStock Editorial via Getty Images

I keep hitting the buy button on Microsoft (NASDAQ:MSFT | MSFT Price Prediction), and the June selloff only made me press it harder. When the tape dragged this stock down to $373 in June while the underlying business printed 18.3% revenue growth, my thesis stopped being a thesis and started feeling like a gift. I own this for the next twenty years of retirement income, through many cycles of noisy headlines.

What pulls me back is boring in the best way. Microsoft sells the plumbing every enterprise on earth now depends on: Windows, Office 365, Azure, GitHub, Dynamics, LinkedIn. Companies do not rip that stack out during a recession. They renew it, expand it, and pay more for it every cycle. That is the cash-flow utility I want anchoring my portfolio.

Three Reasons I Keep Adding

First, the operational reality is running in the opposite direction of the stock chart. Q3 FY26 delivered EPS of $4.27 against a $4.07 estimate, the fourth consecutive beat, on $82.89 billion in revenue. Intelligent Cloud grew 30%, Azure grew 40%, and the AI business now runs at a $37 billion annualized rate, up 123% year over year. Alpha Vantage shows 12 consecutive quarterly beats and an 83.8% beat rate across 130 quarters. That is a compounding machine.

Second, the forward book is enormous. Commercial remaining performance obligations reached $627 billion, up 99%. Contracted revenue at that scale is a multi-year visibility signal I do not get from most large caps. Layer on the restructured OpenAI deal, where Microsoft holds a ~27% stake valued around $135 billion and secured IP rights through 2032 plus an incremental $250 billion Azure commitment, and I own a piece of the frontier without owning the burn.

Third, the balance sheet and returns profile do the heavy lifting. ROE of 33.28%, operating margin of 45.62%, interest coverage of 53.89x, and debt-to-equity of 0.176. Trailing P/E of 22 and forward P/E of 19 on a business compounding EPS at this pace is the kind of setup I rarely get outside of a market panic. The dividend yields only 1.01%, but Microsoft returned $12.7 billion to shareholders last quarter through dividends and buybacks, up 32%.

The Risk I Will Not Wave Away

Capex is the real concern. Q3 capital expenditures hit $30.88 billion, up 84.39%, and Microsoft’s share of OpenAI losses ran $3.1 billion in Q1 FY26 against $523 million a year earlier. If AI monetization stalls, that spend gets ugly. What keeps me buying is the response function on the other side of the ledger: operating income grew 19.99% and operating cash flow grew 26.01% in the same quarter the capex nearly doubled. The customers are paying for the buildout in real time.

I also noticed 13 board members quietly accumulated shares on June 5 during the drawdown, and the Chief Accounting Officer picked up 5,004 shares on June 15. That is a group leaning into its future.

Why the Buy Button Stays Live

Ten-year total return on this stock sits at 724.68%, and the fundamentals underneath it look stronger today than they did at the beginning of that run. When the market hands me a global cash-flow utility at 19 times forward earnings with a $627 billion backlog, I do not overthink it. I buy the plumbing, collect the compounding, and let time do the rest.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

MRNA Vol: 7,596,446
BSX Vol: 11,267,951
UHS Vol: 464,861
DECK Vol: 841,391
HCA Vol: 748,004

Top Losing Stocks

TER Vol: 1,932,530
KLA
KLAC Vol: 7,914,605
GLW Vol: 11,059,662
LRCX Vol: 6,335,969
CTRA Vol: 73,319,495